secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oric Pharmaceuticals, Inc. (ORIC)
CIK:        0001796280
Form:       8-K
Filed at:   2026-07-30T20:49:21+00:00
Accession:  0001193125-26-326309
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ORIC Pharmaceuticals increases inducement equity plan share reserve by 1.1M shares to 3.35M total
--------------------------------------------------------------------------------

- Board approved Amended and Restated 2022 Inducement Plan, adding 1,100,000 shares of common stock.
- Total shares reserved under the plan now 3,350,000 for equity awards to new employees.
- Plan allows grants of nonstatutory stock options, RSUs, SARs, performance shares/units.
- Adopted without stockholder approval per Nasdaq Listing Rules as inducement grants.
- Plan terms are substantially similar to the company's 2020 Equity Incentive Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1796280/000119312526326309/0001193125-26-326309-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1796280/000119312526326309/d169933d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-326309

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer